研发管理团队 > 科研论文-盛齐安丨九游会平台怎么样生物科技股份有限公司—官方网站

盛齐安概况

盛齐安简介领导关怀公司荣誉合作机构发展历程

研发管理团队

研发管理团队技术简介科研论文专利证书重大项目

九游会平台怎么样

载药囊泡治疗恶性胸腔积液技术载药囊泡治疗胆道恶性梗阻技术

新闻中心

公司动态媒体报道员工风采行业新闻投资者关系

患者招募

恶性胸腔积液患者招募（一）恶性胸腔积液患者招募（二）恶性腹水患者招募（一）恶性腹水患者招募（二）恶性腹水患者招募（三）恶性腹水患者招募（四）胆管癌患者招募（一）胆管癌患者招募（二）

招贤纳才

联系九游会平台怎么样

联系方式在线留言

盛齐安概况

盛齐安简介领导关怀公司荣誉合作机构发展历程

研发管理团队

研发管理团队技术简介科研论文专利证书重大项目

九游会平台怎么样

载药囊泡治疗恶性胸腔积液技术载药囊泡治疗胆道恶性梗阻技术

公司动态媒体报道员工风采行业新闻投资者关系

恶性胸腔积液患者招募（一）恶性胸腔积液患者招募（二）恶性腹水患者招募（一）恶性腹水患者招募（二）恶性腹水患者招募（三）恶性腹水患者招募（四）胆管癌患者招募（一）胆管癌患者招募（二）

联系九游会平台怎么样

联系方式在线留言

研发管理团队

技术发明人

研发团队概况

技术作用效应

科研论文

主页 > 研发管理团队 > 科研论文

公司研发团队在全球顶级学术期刊《Nature Materials》、《Nature Communications》、《Cell Research》等系列发表“载药囊泡治疗肿瘤技术”相关文章20余篇，引用次数高达2000余次，最高单篇影响因子达38以上。

2020.07
题为Chemotherapeutic Tumor Microparticles Elicit a Neutrophil Response Targeting Malignant Pleural Effusions在 Cancer Immunology Research 杂志上发表。 (IF: 8.728 )

2020.07
题为Mobilization of neutrophils by MTX-packaging tumor microparticles confers treatment efficacy for obstructive cholangiocarcinoma 在Nature Biomedical Engineering杂志上发表。 (IF: 18.952 )

2019.10
题为Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1β 在Cellular & Molecular Immunology 杂志上发表。 (IF: 8.484)

2019.05
题为The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency 在Nature Biomedical Engineering 杂志上发表。 (IF: 18.952)

2019.01
题为Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion 在 Science Translational Medicine 杂志上发表。 (IF: 16.304)

2018.09

题为Circulating tumor microparticles promote lung metastasis by reprogramming inflammatory and mechanical niches via a macrophage-dependent pathway在 Cancer Immunology Research 杂志上发表。 (IF: 8.728)

2018.09

题为Mechanisms underlying presentation of tumor microparticle antigens to CD8+ T cells by dendritic cells在 Cancer Immunology Research 杂志上发表。(IF: 8.728)

2017.03

题为Chemotherapeutic tumor microparticles combining low dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway在 OncoImmunology 杂志上发表。(IF: 5.869)

2017.01

题为Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity在 OncoImmunology 杂志上发表。(IF: 5.869)

2017.01

题为Pre-instillation of tumor microparticles enhances intravesical chemotherapy of nonmuscle-invasive bladder cancer through a lysosomal pathway在 Biomaterials 杂志上发表。 (IF=10.317)

2016.06

题为Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles在 Cell Research 杂志上发表。(IF=20.507)

2016 .05

题为Delivery of oncolytic adenovirus into thenucleus of tumorigenic cells by tumor microparticles for virotherapy 在 Biomaterials 杂志上发表。 (IF=10.317)

2016 .02

题为Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression 在杂志上 Oncoimmunology 发表。(IF: 5.869)

2015 .05

题为Tumor cell-derived microparticles: a new form of cancer vaccine在 Oncoimmunology 杂志上发表。(IF: 5.869)

2015 .04

题为Microparticles mediate human papillomavirus type 6 or 11 infection of human macrophages 在 Cellular & Molecular Immunology 杂志上发表。(IF: 8.484)

2015 .02

题为Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling 在 Cancer Immunology Research 杂志上发表。(IF: 8.728)

2012 .12

题为Delivery of chemotherapeutic drugs in tumourcell-derived microparticles 在Nature Communications上发表。 (IF: 12.121)

2012.10

题为Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity在 Cellular & Molecular Immunology 上发表。(IF: 8.484)

2012 .08

题为TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b 在OncoImmunology上发表。(IF: 5.869)

2012 .07

题为Soft fibrin gels promote selection and growth of tumorigenic cells 在 Nature Materials 上发表。(IF: 38.663)

2010 .10

题为Innate Immune Cell-Derived Microparticles Facilitate Hepatocarcinoma Metastasis by Transferring Integrin aMb2 to Tumor Cells 在 Journal Immunology 上发表。 (IF: 4.886)

2010 .08